Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from GENOVA Inc. ( (JP:9341) ) is now available.
GENOVA Inc. will absorb its wholly owned subsidiary GENOVA DESiGN Inc. in an absorption-type merger effective April 1, 2026, with GENOVA as the surviving entity and the design unit to be dissolved. GENOVA DESiGN, which has handled web design and content production, will be integrated to tighten collaboration with the Medical Platform Business, accelerate decision-making, enhance service quality and streamline management by cutting administrative costs.
The transaction is structured as a simplified and short-form merger under Japan’s Companies Act, so no shareholder meetings will be held at either company, and no new shares or cash consideration will be issued. As GENOVA DESiGN has no share acquisition rights or related bonds, the integration is procedurally straightforward, signaling an internal reorganization aimed at operational efficiency rather than a change in external capitalization or ownership structure.
The most recent analyst rating on (JP:9341) stock is a Hold with a Yen612.00 price target. To see the full list of analyst forecasts on GENOVA Inc. stock, see the JP:9341 Stock Forecast page.
More about GENOVA Inc.
GENOVA Inc., listed on the Tokyo Stock Exchange Prime Market under ticker 9341, operates a Medical Platform Business, Smart Clinic Business, Dental Distribution Business and DX Business. The company develops and operates medical-related services and digital transformation solutions, with a focus on healthcare platforms and associated clinic and dental distribution operations in Japan.
Average Trading Volume: 101,898
Technical Sentiment Signal: Hold
Current Market Cap: Yen10.97B
For a thorough assessment of 9341 stock, go to TipRanks’ Stock Analysis page.